Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer

Autor: Wortman, B.G., Astreinidou, E., Laman, M.S., van der Steen-Banasik, E.M., Lutgens, L.C.H.W., Westerveld, H., Koppe, F., Slot, A., van den Berg, H.A., Nowee, M.E., Bijmolt, S., Stam, T.C., Zwanenburg, A.G., Mens, J.W.M., Jürgenliemk-Schulz, I.M., Snyers, A., Gillham, C.M., Weidner, N., Kommoss, S., Vandecasteele, K., Tomancova, V., Creutzberg, C.L., Nout, R.A.
Zdroj: In Radiotherapy and Oncology February 2021 155:160-166
Databáze: ScienceDirect